Severity of thyrotoxicosis is a risk factor for excessive weight gain in treated hyperthyroidism
European Thyroid Journal · 2025
DOI: 10.1530/etj-24-0373 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Thyroid Journal, 2025. Verfasst von Angelos Kyriacou und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, European University Cyprus, Nicosia, Cyprus. Hauptthemen laut MEDLINE: Weight Gain, Hyperthyroidism, Antithyroid Agents, Thyrotoxicosis. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Objective
Hyperthyroidism is characterized by weight fluctuations and overshoot of weight regain following treatment. We aimed to identify parameters predicting peak percentage weight gain (PWG) in the post-treatment period.
Methods
We included 110 patients (73 (66.4%) women) with hyperthyroidism 6–36 months after treatment initiation. The primary outcome was PWG of ≥10% (group A) or <10% (group B). We performed adjusted analyses by logistic regression with age, sex, disease-related weight loss, hypothyroidism occurrence, free T4 at diagnosis (fT4-t0) and disease duration as independent variables.
Results
Post-treatment mean (SD) weight gain was 7.4 (5.22) kg, whereas disease-related weight loss was 5.3 (5.15) kg. Group A (52.7% participants) compared to group B had significantly higher median (IQR) fT4-t0 at 47.4 (36.2, 97.2) vs 29.3 (22.8, 40.4) ng/dL (P < 0.001) and disease-related weight loss at 6.8 (3, 10) vs 2.5 (0, 4.8) kg (P < 0.001) and non-significantly higher presentation free triiodothyronine at 19.6 (10.4, 44.1) vs 11.8 (8.7, 22.9) pg/mL (P = 0.078) and TRAb at 6.3 (3, 16.1) vs 4.2 (2.4, 8.7) IU/L (P = 0.093), respectively. Significant predictor variables of post-treatment PWG in logistic regression were disease-related weight loss (OR = 1.23, P = 0.002) and fT4-t0 (OR = 1.04, P = 0.008).
Conclusion
More than half the patients with hyperthyroidism had ≥10% PWG post-treatment. Indicators of disease severity, namely disease-related weight loss and baseline thyroid hormones, were predictive of excessive weight gain post-treatment and could be utilized for risk stratification and early intervention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Medicine, European University Cyprus, Nicosia, Cyprus.
- CEDM Centre of Endocrinology, Diabetes & Metabolism, Limassol, Cyprus.
- Diabetes, Endocrinology & Obesity Medicine, Salford Royal Hospital, Northern Care Alliance NHS Foundation Trust, Salford, UK.
- School of Health Sciences, University of Stirling, Stirling, UK.
- Center of Excellence in Biobanking and Biomedical Research, University of Cyprus, Nicosia, Cyprus.
- Alithias Endocrinology Center, Nicosia, Cyprus.
ORCID-Profile: Angelos Kyriacou, Economides Panayiotis
Zitieren
APA
Kyriacou, A., Vryza, P., Kyriacou, A., Picolos, M., Lamnisos, D., Panayiotis, E., & Syed, A. A. (2025). Severity of thyrotoxicosis is a risk factor for excessive weight gain in treated hyperthyroidism. European Thyroid Journal. https://doi.org/10.1530/etj-24-0373
Vancouver
Kyriacou A, Vryza P, Kyriacou A, Picolos M, Lamnisos D, Panayiotis E, et al. Severity of thyrotoxicosis is a risk factor for excessive weight gain in treated hyperthyroidism. European Thyroid Journal. 2025. doi:10.1530/etj-24-0373
BibTeX
@article{Kyriacou2025,
author = {Kyriacou, Angelos and Vryza, Paraskevi and Kyriacou, Alexis and Picolos, Michalis and Lamnisos, Demetris and Panayiotis, Economides and Syed, Akheel A},
title = {Severity of thyrotoxicosis is a risk factor for excessive weight gain in treated hyperthyroidism},
journal = {European Thyroid Journal},
year = {2025},
doi = {10.1530/etj-24-0373}
}
EUVIMED